Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEACOPP in Pediatric Advanced Hodgkin's Disease
NCT00004010Phase 2Completed
- Sponsor
- Children's Oncology Group
- Start
- Oct 1999
- Primary completion
- Oct 2003
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine in Hodgkin lymphoma (HL), sponsored by Children's Oncology Group. Started Oct 1999; status: completed.
02
Drugs
bleomycinetoposidedoxorubicincyclophosphamidevincristine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00004010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004010.